Attached files

file filename
EX-1.01 - EXHIBIT 1.01 - JRSIS HEALTH CARE Corpv403997_ex1-01.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 4, 2015

 

JRSIS HEALTH CARE CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

 Florida   333-194359   46-4562047
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer 
of Incorporation)       Identification No.)

 

1 st – 7 th Floor, Industrial and Commercial Bank Building,
Xingfu Street, Hulan Town, Hulan District, Harbin City,

Heilongjiang Province, China 150025

 (Address of Principal Executive Offices) (Zip Code)

 

0086-451-56888933

Registrant’s telephone number, including area code

 

 

(Former Name or Former Address

if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

  

Item 1.01 Entry into a Material Definitive Agreement.

 

On March 4, 2015, JRSIS Health Care Corporation (the “Company”) entered into a letter agreement (the “Engagement Letter”) with Halcyon Cabot Partners, Ltd. (“HCP”), whereby HCP agrees to provide certain advisory and consulting services to the Company in connection with its current offering of securities. A copy of the Engagement Letter is attached hereto as Exhibit 1.01 and incorporated herein by reference.

 

Item 9.01Financial Statements and Exhibits

 

(d)Exhibits

 

Exhibit No. Description
   
1.01 Letter Agreement dated March 4, 2015 between Halcyon Cabot Partners, Ltd. And the Company.
   

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: March 9, 2015  
   
JRSIS HEALTH CARE CORPORATION  
   
By:   /s/ Lihua Sun  
  Name:  Lihua Sun  
  Title:   Chief Executive Officer      
   
   

 

EXHIBIT 1.01

Letter Agreement